Sight Sciences, Inc.(SGHT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SGHT Sight Sciences, Inc.

Pre-Market Trading 04-09 07:10:22 EDT

2.09

-0.12

-5.43%

High2.41	Low2.03	Vol193.77K
Open2.30	D1 Closing2.21	Amplitude17.19%
Mkt Cap107.29M	Tradable Cap65.86M	Total Shares51.33M
T/O422.80K	T/O Rate0.61%	Tradable Shares31.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"SGHT","market":"US","secType":"STK","nameCN":"Sight Sciences, Inc.","latestPrice":2.09,"timestamp":1744142400000,"preClose":2.21,"halted":0,"volume":193765,"delay":0,"floatShares":31509819,"shares":51332694,"eps":-1.027384,"marketStatus":"Pre-Market Trading","change":-0.12,"latestTime":"04-09 07:10:22 EDT","open":2.3,"high":2.41,"low":2.03,"amount":422803.6115,"amplitude":0.171946,"askPrice":3.34,"askSize":200,"bidPrice":1.83,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.027384,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1744205400000},"marketStatusCode":1,"adr":0,"listingDate":1626321600000,"exchange":"NASDAQ","adjPreClose":2.09,"postHourTrading":{"tag":"盘后","latestPrice":2.09,"preClose":2.09,"latestTime":"16:33 EDT","volume":1301,"amount":2718.77,"timestamp":1744144391351},"volumeRatio":0.6746490393256791,"impliedVol":0.4332,"impliedVolPercentile":0.16},"requestUrl":"/m/hq/s/SGHT","defaultTab":"news","newsList":[{"id":"2523986146","title":"Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough","url":"https://stock-news.laohu8.com/highlight/detail?id=2523986146","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523986146?lang=en_us&edition=full_marsco","pubTime":"2025-03-30 21:54","pubTimestamp":1743342851,"startTime":"0","endTime":"0","summary":"Sight Sciences, Inc.'s ( NASDAQ:SGHT ) price-to-sales (or \"P/S\") ratio of 1.6x might make it look like a buy right now...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-sght/sight-sciences/news/sight-sciences-inc-nasdaqsght-looks-inexpensive-but-perhaps","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2095319765.USD","LU2210150020.SGD","IE00BGHQF748.EUR","NVIW.SI","LU2210149790.SGD","TQQQ","IE00B3QW5Z07.USD","SGHT","NDAQ","BK4539","BK4082","MNQmain","USJW.SI","PSQ","NQmain","IE00B64PRP62.GBP","TSYW.SI","BK4112",".IXIC","USAW.SI","IE00BKPKM429.USD","QLD","BK4588","QID","SQQQ","BK4585"],"gpt_icon":1},{"id":"2522833388","title":"Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th","url":"https://stock-news.laohu8.com/highlight/detail?id=2522833388","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522833388?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:05","pubTimestamp":1742933100,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., March 25, 2025  -- Sight Sciences, Inc.  , an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced plans to present at the 24th Annual Needham Healthcare Conference being held virtually.Sight Sciences, the Sight Sciences logo, TearCare, SmartHub and SmartLids are trademarks of Sight Sciences registered in the United States. OMNI and SION are trademarks of Sight Sciences registered in the United States, European Union and other territories.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sight-sciences-present-24th-annual-200500324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4137","BK4082","SGHT","HCSG"],"gpt_icon":0},{"id":"2517143634","title":"Sight Sciences’ Earnings Call: Cautious Optimism Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2517143634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517143634?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 08:24","pubTimestamp":1741307050,"startTime":"0","endTime":"0","summary":"Sight Sciences, Inc. (($SGHT)) has held its Q4 earnings call. Read on for the main highlights of the call. Sight Sciences, Inc. recently held its e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sight-sciences-earnings-call-cautious-optimism-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sight-sciences-earnings-call-cautious-optimism-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2517482196","title":"Q4 2024 Sight Sciences Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482196","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482196?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 01:09","pubTimestamp":1741280969,"startTime":"0","endTime":"0","summary":"Paul Badawi; President, Chief Executive Officer, Co-Founder, Director; Sight Sciences Inc. Alison Bauerlein; Chief Financial Officer, Chief Accounting Officer, Treasurer; Sight Sciences Inc. Matthew Link; Chief Commercial Officer; Sight Sciences Inc. Thomas Stephan; Analyst; Stifel Nicolaus and Company, Incorporated. Hello and welcome to the Sight Sciences fourth-quarter 2024 earnings conference call.  Please be advised that today's conference is being recorded.It is now my pleasure to introduce Trip Taylor, Investor Relations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-sight-sciences-inc-170929256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SGHT"],"gpt_icon":0},{"id":"2517696331","title":"Sight Sciences Is Maintained at Neutral by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2517696331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517696331?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 22:54","pubTimestamp":1741272840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGHT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2025 09:54 ET (14:54 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0},{"id":"2517168857","title":"Sight Sciences price target lowered to $2.50 from $3 at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168857?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:46","pubTimestamp":1741268816,"startTime":"0","endTime":"0","summary":"Lake Street analyst Frank Takkinen lowered the firm’s price target on Sight Sciences (SGHT) to $2.50 from $3 and keeps a Hold rating on the shares....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-lowered-to-2-50-from-3-at-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-lowered-to-2-50-from-3-at-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2517015995","title":"Sight Sciences price target lowered to $4 from $5 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2517015995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517015995?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 20:06","pubTimestamp":1741262809,"startTime":"0","endTime":"0","summary":"Stifel lowered the firm’s price target on Sight Sciences (SGHT) to $4 from $5 and keeps a Buy rating on the shares. 2025 revenue guidance of $70M-$...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-lowered-to-4-from-5-at-stifel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-lowered-to-4-from-5-at-stifel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT","SF"],"gpt_icon":0},{"id":"2517156975","title":"Sight Sciences: Hold Rating Amid Revenue Challenges and Reimbursement Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2517156975","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517156975?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 19:58","pubTimestamp":1741262295,"startTime":"0","endTime":"0","summary":"Needham analyst David Saxon has maintained their neutral stance on SGHT stock, giving a Hold rating today. David Saxon’s rating is based on a combi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sight-sciences-hold-rating-amid-revenue-challenges-and-reimbursement-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sight-sciences-hold-rating-amid-revenue-challenges-and-reimbursement-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","SGHT"],"gpt_icon":0},{"id":"2517615690","title":"Sight Sciences price target lowered to $3.50 from $5.50 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2517615690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517615690?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 19:56","pubTimestamp":1741262173,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Sight Sciences (SGHT) to $3.50 from $5.50 and keeps a Neutral rating on the s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-lowered-to-3-50-from-5-50-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-lowered-to-3-50-from-5-50-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2517615352","title":"Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Envista Holdings (NVST) and Sight Sciences (SGHT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517615352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517615352?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 19:20","pubTimestamp":1741260023,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Veeva Systems (VEEV – Research Report), Envista Holdings (NVST – Research Report) and Sight Sciences ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-veeva-systems-veev-envista-holdings-nvst-and-sight-sciences-sght?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-veeva-systems-veev-envista-holdings-nvst-and-sight-sciences-sght?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","LU1201861165.SGD","LU0058720904.USD","BK4137","BK4539","VEEV","BK4534","LU0477156797.USD","BK4588","SGHT","LU0130518102.USD","LU1989764664.SGD","BK4504","LU0130103400.USD","LU0289739699.SGD","BK4585","HCSG","LU1989764748.USD","NVST","LU0648000940.SGD","BK4528","BK4082","LU0266013472.USD"],"gpt_icon":0},{"id":"2517305441","title":"Sight Sciences Faces Headwinds in Glaucoma and Dry Eye Markets, Hold Rating Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2517305441","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517305441?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 18:30","pubTimestamp":1741257026,"startTime":"0","endTime":"0","summary":"William Blair analyst Margaret Kaczor has maintained their neutral stance on SGHT stock, giving a Hold rating on March 4. Margaret Kaczor’s rating ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sight-sciences-faces-headwinds-in-glaucoma-and-dry-eye-markets-hold-rating-maintained?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sight-sciences-faces-headwinds-in-glaucoma-and-dry-eye-markets-hold-rating-maintained?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2517815761","title":"Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2517815761","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517815761?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 15:11","pubTimestamp":1741245097,"startTime":"0","endTime":"0","summary":"Total Revenue: $19.1 million, a 2% increase compared to the same period in the prior year.Surgical Glaucoma Revenue: $18.8 million, up 9% year-over-year.Dry Eye Revenue: $0.3 million, a decrease from $1.6 million in the prior year.Gross Margin: 87%, an increase from 85% in the prior year.Total Operating Expenses: $28.5 million, a 5% increase from the prior year.Adjusted Operating Expenses: $24.4 million, a 9% increase from the prior year.Net Loss: $11.8 million or $0.23 per share, compared to a net loss of $10.7 million or $0.22 per share in the prior year.Cash and Cash Equivalents: $120.4 million at the end of the quarter.Debt: $40 million, excluding debt discounts and amortized debt issuance costs.Cash Generated: $1.8 million in the fourth quarter, including a $5 million drawdown under the term loan.2025 Adjusted Operating Expenses Guidance: $105 to $107 million, a 4 to 6% increase from 2024.GuruFocus has detected 3 Warning Signs with SGHT.Sight Sciences Inc  reported a 2% increase i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sight-sciences-inc-sght-q4-071137360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SGHT"],"gpt_icon":0},{"id":"2517973111","title":"Sight Sciences Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2517973111","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517973111?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 07:29","pubTimestamp":1741217367,"startTime":"0","endTime":"0","summary":"Sight Sciences Inc reports results for the quarter ended December 31 - Earnings SummarySight Sciences Inc SGHT.OQ reported a quarterly adjusted loss of 23 cents per share for the quarter ended Decembe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL5N3PO2GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0},{"id":"2517971024","title":"Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2517971024","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517971024?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 07:00","pubTimestamp":1741215606,"startTime":"0","endTime":"0","summary":"For the quarter ended December 2024, Sight Sciences, Inc.  reported revenue of $19.07 million, up 1.7% over the same period last year. EPS came in at -$0.23, compared to -$0.22 in the year-ago quarter.The reported revenue represents a surprise of +0.50% over the Zacks Consensus Estimate of $18.98 million. With the consensus EPS estimate being -$0.20, the EPS surprise was -15.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Sight Sciences performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:. Shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/compared-estimates-sight-sciences-sght-230006801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SGHT"],"gpt_icon":0},{"id":"2517975041","title":"Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2517975041","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517975041?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 06:20","pubTimestamp":1741213204,"startTime":"0","endTime":"0","summary":"Sight Sciences, Inc.  came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -15%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.22, delivering a surprise of 4.35%.Sight Sciences , which belongs to the Zacks Medical - Instruments industry, posted revenues of $19.07 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.50%. This compares to year-ago revenues of $18.75 million. The company has topped consensus revenue estimates three times over the last four quarters.Sight Sciences shares have lost about 32.1% since the beginning of the year versus the S&P 500's decline of -1.8%.While Sight Sciences has underperformed the market so far this year, the question that co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sight-sciences-inc-sght-reports-222004903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SGHT"],"gpt_icon":0},{"id":"2517217924","title":"Sight Sciences sees FY25 revenue $70M-$75M, consensus $78.07M","url":"https://stock-news.laohu8.com/highlight/detail?id=2517217924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517217924?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 05:37","pubTimestamp":1741210651,"startTime":"0","endTime":"0","summary":"Sight Sciences (SGHT) expects its revenue for full year 2025 to range from $70M to $75M, representing a 6% to 12% decline compared to full year 202...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sight-sciences-sees-fy25-revenue-70m-75m-consensus-78-07m?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sight-sciences-sees-fy25-revenue-70m-75m-consensus-78-07m?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2517924295","title":"Sight Sciences Reports 2024 Financial Results and 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2517924295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517924295?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 05:31","pubTimestamp":1741210304,"startTime":"0","endTime":"0","summary":"The latest update is out from Sight Sciences ( ($SGHT) ). On March 5, 2025, Sight Sciences reported its financial results for the fourth quarter an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sight-sciences-reports-2024-financial-results-and-2025-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sight-sciences-reports-2024-financial-results-and-2025-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","SGHT","BK4082"],"gpt_icon":0},{"id":"2517242659","title":"Sight Sciences reports Q4 EPS (23c), consensus (18c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517242659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517242659?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 05:30","pubTimestamp":1741210240,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $$19.1M, consensus $19M.”As we turn to 2025, we are focused on advancing our strategic initiatives, which include building comme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sight-sciences-reports-q4-eps-23c-consensus-18c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sight-sciences-reports-q4-eps-23c-consensus-18c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2517921594","title":"Sight Sciences Q4 2024 GAAP EPS $(0.23) Misses $(0.21) Estimate, Sales $19.100M Miss $19.924M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921594","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921594?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 05:08","pubTimestamp":1741208900,"startTime":"0","endTime":"0","summary":"Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 4.55 percent decrease over losses of $(0.22) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44151874/sight-sciences-q4-2024-gaap-eps-0-23-misses-0-21-estimate-sales-19-100m-miss-19-924m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Sight Sciences Q4 2024 GAAP EPS $(0.23) Misses $(0.21) Estimate, Sales $19.100M Miss $19.924M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0},{"id":"2517043929","title":"BRIEF-Sight Sciences Q4 Revenue USD 19.1 Million Vs. IBES Estimate USD 19.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517043929","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517043929?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 05:05","pubTimestamp":1741208746,"startTime":"0","endTime":"0","summary":"BRIEF-Sight Sciences Q4 Revenue USD 19.1 Million Vs. IBES Estimate USD 19.9 Million\n\n\nMar 05 (Reuters) - Sight Sciences Q4 gross profit USD 16.6 million.\n\nQ4 net income USD -11.8 million vs. IBES estimate USD -9.89 million\nQ4 gross margin 87%\nQ4 operating expenses USD 28.5 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLX6E568B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sightsciences.com","stockEarnings":[{"period":"1week","weight":-0.0873},{"period":"1month","weight":-0.1144},{"period":"3month","weight":-0.3705},{"period":"6month","weight":-0.6234},{"period":"1year","weight":-0.613},{"period":"ytd","weight":-0.4258}],"compareEarnings":[{"period":"1week","weight":-0.115},{"period":"1month","weight":-0.1379},{"period":"3month","weight":-0.1578},{"period":"6month","weight":-0.1383},{"period":"1year","weight":-0.0429},{"period":"ytd","weight":-0.1529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.158431},{"month":2,"riseRate":0.25,"avgChangeRate":0.009629},{"month":3,"riseRate":0.25,"avgChangeRate":-0.080232},{"month":4,"riseRate":0.5,"avgChangeRate":-0.091954},{"month":5,"riseRate":0.666667,"avgChangeRate":0.134789},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.024422},{"month":7,"riseRate":1,"avgChangeRate":0.087159},{"month":8,"riseRate":0,"avgChangeRate":-0.216342},{"month":9,"riseRate":0,"avgChangeRate":-0.21127},{"month":10,"riseRate":0.5,"avgChangeRate":-0.078711},{"month":11,"riseRate":0.5,"avgChangeRate":0.288194},{"month":12,"riseRate":0.5,"avgChangeRate":0.089312}],"exchange":"NASDAQ","name":"Sight Sciences, Inc.","nameEN":"Sight Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sight Sciences, Inc.(SGHT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sight Sciences, Inc.(SGHT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sight Sciences, Inc.,SGHT,Sight Sciences, Inc.股票,Sight Sciences, Inc.股票老虎,Sight Sciences, Inc.股票老虎国际,Sight Sciences, Inc.行情,Sight Sciences, Inc.股票行情,Sight Sciences, Inc.股价,Sight Sciences, Inc.股市,Sight Sciences, Inc.股票价格,Sight Sciences, Inc.股票交易,Sight Sciences, Inc.股票购买,Sight Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sight Sciences, Inc.(SGHT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sight Sciences, Inc.(SGHT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}